MedPath

Evaluation of pubertal and hormone development in boys who stored testicular tissue for fertility preservation before a treatment possibly leading to later fertility problems

Not Applicable
Conditions
Childhood cancer, childhood hematological disease
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN13057463
Lead Sponsor
niversitair Ziekenhuis Brussel
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
Male
Target Recruitment
100
Inclusion Criteria

Current inclusion criteria as of 11/01/2021:

1. Pre- and peripubertal boys (<18 years) who do not yet produce mature spermatozoa
2. Diagnosis of childhood cancer or childhood hematological disorders (<18 years) at the Universitair Ziekenhuis Brussel or the Hôpital Universitaire Des Enfants Reine Fabiola
3. High-risk gonadotoxic treatment (with an =80% risk of later fertility problems)
4. Did or did not undergo a testicular tissue biopsy procedure at a young age as a fertility preservation strategy

_____

Previous inclusion criteria:

1. Pre- and peripubertal boys (<18 years) who do not yet produce mature spermatozoa
2. Diagnosis of childhood cancer or childhood hematological disorders (<18 years) at the Universitair Ziekenhuis Brussel
3. High-risk gonadotoxic treatment (with an =80% risk of later fertility problems)
4. Did or did not undergo a testicular tissue biopsy procedure at a young age as a fertility preservation strategy

Exclusion Criteria

1. Diagnosis of testicular cancer

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath